USFDA inspection: Laurus Labs arm gets 5 observations for AP facility
Advertisement
Hyderabad: Laurus Synthesis Private Limited (LSPL), a wholly owned subsidiary of Laurus Labs, has received a Form 483 with five observations from the United States Food and Drug Administration (USFDA) for the manufacturing facility in Parawada, Anakapalli, near Visakhapatnam, Andhra Pradesh.
The inspection was conducted from 4th December, 2023 to 12th December, 2023.
"We have been issued a Form 483 with five observations, and the Company will address the observations within stipulated timelines," the Company stated in a BSE filing.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.